Cargando…

First report of Burkholderia pseudomallei ST412 and ST734 clones harbouring blaOXA-57 but susceptible to imipenem in India

Melioidosis caused by Burkholderia pseudomallei has become an important clinical threat, especially in Northern Australia and Southeast Asia. However, the genome information on this pathogen is limited. B. pseudomallei isolates identified from bloodstream infections from inpatients were subjected to...

Descripción completa

Detalles Bibliográficos
Autores principales: Amladi, A., Devanga Ragupathi, N.K., Vasudevan, K., Venkatesan, M., Anandan, S., Veeraraghavan, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849412/
https://www.ncbi.nlm.nih.gov/pubmed/31737280
http://dx.doi.org/10.1016/j.nmni.2019.100613
_version_ 1783469201324769280
author Amladi, A.
Devanga Ragupathi, N.K.
Vasudevan, K.
Venkatesan, M.
Anandan, S.
Veeraraghavan, B.
author_facet Amladi, A.
Devanga Ragupathi, N.K.
Vasudevan, K.
Venkatesan, M.
Anandan, S.
Veeraraghavan, B.
author_sort Amladi, A.
collection PubMed
description Melioidosis caused by Burkholderia pseudomallei has become an important clinical threat, especially in Northern Australia and Southeast Asia. However, the genome information on this pathogen is limited. B. pseudomallei isolates identified from bloodstream infections from inpatients were subjected to whole-genome sequencing by IonTorrent PGM and MinION Oxford Nanopore sequencing technologies. Highly accurate complete genomes of two strains, VB3253 and VB2514, were obtained by a hybrid genome assembly method using both short and long DNA reads. Both isolates carried blaPenI and carbapenemase-encoding blaOXA-57 genes, although the isolates were susceptible to imipenem by E-test method with MIC 1 μg/mL. Multiple IS family transposases specific for all non-fermenting Gram-negative bacteria (NFGNBs)—especially IS3 and IS5, which facilitate mobilization of extended-spectrum β-lactamase (ESBL) and carbapenemase genes—were carried in these genomes. This further adds to the complexity of gene transmission. These IS families were identified only upon hybrid genome assembly and would otherwise be missed.
format Online
Article
Text
id pubmed-6849412
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-68494122019-11-15 First report of Burkholderia pseudomallei ST412 and ST734 clones harbouring blaOXA-57 but susceptible to imipenem in India Amladi, A. Devanga Ragupathi, N.K. Vasudevan, K. Venkatesan, M. Anandan, S. Veeraraghavan, B. New Microbes New Infect New Resistant Microbes in Human Melioidosis caused by Burkholderia pseudomallei has become an important clinical threat, especially in Northern Australia and Southeast Asia. However, the genome information on this pathogen is limited. B. pseudomallei isolates identified from bloodstream infections from inpatients were subjected to whole-genome sequencing by IonTorrent PGM and MinION Oxford Nanopore sequencing technologies. Highly accurate complete genomes of two strains, VB3253 and VB2514, were obtained by a hybrid genome assembly method using both short and long DNA reads. Both isolates carried blaPenI and carbapenemase-encoding blaOXA-57 genes, although the isolates were susceptible to imipenem by E-test method with MIC 1 μg/mL. Multiple IS family transposases specific for all non-fermenting Gram-negative bacteria (NFGNBs)—especially IS3 and IS5, which facilitate mobilization of extended-spectrum β-lactamase (ESBL) and carbapenemase genes—were carried in these genomes. This further adds to the complexity of gene transmission. These IS families were identified only upon hybrid genome assembly and would otherwise be missed. Elsevier 2019-10-15 /pmc/articles/PMC6849412/ /pubmed/31737280 http://dx.doi.org/10.1016/j.nmni.2019.100613 Text en © 2019 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle New Resistant Microbes in Human
Amladi, A.
Devanga Ragupathi, N.K.
Vasudevan, K.
Venkatesan, M.
Anandan, S.
Veeraraghavan, B.
First report of Burkholderia pseudomallei ST412 and ST734 clones harbouring blaOXA-57 but susceptible to imipenem in India
title First report of Burkholderia pseudomallei ST412 and ST734 clones harbouring blaOXA-57 but susceptible to imipenem in India
title_full First report of Burkholderia pseudomallei ST412 and ST734 clones harbouring blaOXA-57 but susceptible to imipenem in India
title_fullStr First report of Burkholderia pseudomallei ST412 and ST734 clones harbouring blaOXA-57 but susceptible to imipenem in India
title_full_unstemmed First report of Burkholderia pseudomallei ST412 and ST734 clones harbouring blaOXA-57 but susceptible to imipenem in India
title_short First report of Burkholderia pseudomallei ST412 and ST734 clones harbouring blaOXA-57 but susceptible to imipenem in India
title_sort first report of burkholderia pseudomallei st412 and st734 clones harbouring blaoxa-57 but susceptible to imipenem in india
topic New Resistant Microbes in Human
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849412/
https://www.ncbi.nlm.nih.gov/pubmed/31737280
http://dx.doi.org/10.1016/j.nmni.2019.100613
work_keys_str_mv AT amladia firstreportofburkholderiapseudomalleist412andst734clonesharbouringblaoxa57butsusceptibletoimipeneminindia
AT devangaragupathink firstreportofburkholderiapseudomalleist412andst734clonesharbouringblaoxa57butsusceptibletoimipeneminindia
AT vasudevank firstreportofburkholderiapseudomalleist412andst734clonesharbouringblaoxa57butsusceptibletoimipeneminindia
AT venkatesanm firstreportofburkholderiapseudomalleist412andst734clonesharbouringblaoxa57butsusceptibletoimipeneminindia
AT anandans firstreportofburkholderiapseudomalleist412andst734clonesharbouringblaoxa57butsusceptibletoimipeneminindia
AT veeraraghavanb firstreportofburkholderiapseudomalleist412andst734clonesharbouringblaoxa57butsusceptibletoimipeneminindia